- The top hospitals by state, per Forbes
- Dentists could soon play a larger role in vaccine administration: Research
- 8 behavioral health layoffs to know | 2026
- 19 new behavioral health projects to know
- Humana to exit Medicare Advantage plans covering 600,000 members in 2027
- Inside Inova’s 46% release fill rate: Turning open OR time into more cases
- 26 new behavioral health study findings to know
- Why solo dentistry could soon be on the way out
- The survival test for provider-sponsored health plans
- CMS finalizes payment rules for inpatient psychiatric, skilled nursing facilities: 12 things to know
- Feds’ ER records request leaves systems in limbo
- Qilin ransomware racks up 168 healthcare victims
- Inside UVM Health’s affordability-centered response to a $220M revenue hit
- The 5 biggest health system layoffs in 2026
- FTC sues Hims & Hers over health data sharing, billing practices
- Real estate firm acquires newly built ASC in Wisconsin
- California urology group joins PE-backed Unio
- Dental school debt vs. medical school debt: 4 stats
- Children’s Hospital Los Angeles appoints Dr. Andrew Costandi as anesthesiologist-in-chief
- FTC sues Hims & Hers over data privacy, billing practices
- GEICO accuses 2 NYC physician groups of $2M fraud scheme
- MOB deal activity dropped $655M in Q2: 6 things to know
- How this North Carolina surgeon dodged a $2M ASC build-out
- ‘You can’t out-recruit a retention problem’: Inside dentistry’s labor crisis
- The shifting dental payer landscape
- New York City dental practices named in deceptive treatment financing lawsuit
- The ChatGPT, health tech vendor reckoning
- Oregon psychiatric hospital cuts 34 beds, to lay off 45 employees
- Who’s buying up spine practices?
- 15 rising stars in orthopedic surgery
- CMS' proposed 340B reimbursement cut—who wins, and who loses?
- American Gastroenterological Association CEO to retire after 12 years
- Virtual care helps patients improve their gambling disorder symptoms, Birches Health finds
- Texas DSO hit with cyberattack affecting 30,000 individuals
- How 3 Connecticut hospitals responded to rising psychiatric ED demand
- Nuvia Dental Implant Center to open in Texas
- Specialty1 Partners enters joint venture with Ohio periodontal practice
- Federal judge halts mental health grant terminations, again: 7 notes
- Acadia reports $10.9M Q2 profit, down 64% year over year
- CMS ending Medicare Part D subsidy program
- Red Cross Declares Rare National Blood Supply Crisis Amid Summer Shortfall
- Not Just Pregnancy Fatigue: Could It Be Sleep Apnea?
- More Women Drinking During Pregnancy
- HHS launches behavioral health pledge as Optum preps new services
- Wellstar Health System lays off 761 corporate, administrative staff
- Biogen flips '26 guidance from expected decline to sales increase
- Teva’s innovation engine offsets generics slump, leaving one analyst ‘shocked’ by Ajovy’s surge
- Talking To Your Baby? Eye Contact Is Key To Language Development, Experiment Shows
- Boosted by CMS settlement, Incyte expects Opzelura to cross $1B in 2026
- Leapfrog launches expanded ASC public reporting program
- Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead
- DoorDash, GrubHub Delivering Junk Food To 1 In 4 Teens During School Hours
- Hospice’s Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Trump Has Quietly Throttled an Agency Devoted to the Safety of American Healthcare
- Uninsured but Undaunted, a Surgical Patient Searched the Globe for a Deal
- A look at CVS’ march toward a simpler patient experience
- Humana plans more market exits for 2027, CFO says
- PMCPA sanctions melatonin drugmaker over misleading information
- The high stakes of pediatric dental sedation: Understanding the clinical and legal risks facing pediatric dentists
- AI doctor startup Doctronic acquires Summer Health to move into pediatric care
- Autistic patients less likely to receive on-time cancer screening: Study
- Rare disease foundation partners with Citizen Health to embed AI agent into everyday care
- Community Medical’s CEO on Medicaid cuts: ‘It’s not something that keeps me up at night’
- AI, energy prices will strain hospitals' non-labor spending in 2027: Vizient
- CG Life embraces next-gen era in merger with AI-native agency The Considered+AI
- How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval
- American Red Cross declares second-ever national blood supply crisis, urges ‘immediate’ donations
- Fifth Death Reported In NYC Legionnaires' Disease Outbreak
- Universal Health Services tops Q2 expectations, but dials back full-year earnings
- Many Young Adults Aren't Ready To Manage Their Own Healthcare, Poll Finds
- Can A Daily Multivitamin Help You Stay Active As You Age?
- With $5.5B settlement offer, J&J could be on its way to resolving talc litigation
- Prebiotic Soda Health Claims Questioned In New Nutrition Study
- Family-Based Childhood Obesity Program Helps Kids Cut Weight, Become Healthier
- To Afford Aging In Place, Older Adults Turn To 'Golden Girls' Housing
- Breakfast Can Help Teens Make Better Food Choices Throughout Their Day, Study Says
- GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain
- Newsom Reverses on Long-Sought Paid Leave Benefit for Teachers in California
- Federal Loan Caps Add Barriers — And Likely Debt — for Healthcare Students
- Cyclospora Boosts Fears That Worse Foodborne Outbreaks Are Ahead
- Margin improvements underpin Centene's strategy for 2027 ACA plans, CEO says
- Baxter issues recall of antibiotic IV bags after bits of cardboard flagged in solution
- Havas Lynx revamps New York C-suite 16 months after last shakeup
- LifeBridge Health deploys Prenosis' FDA-authorized AI tool to speed sepsis detection
- Included Health inks agreement to acquire Firefly Health to scale alternative health plans for employers
- Gilead uses humor, relatability in ‘Up to Date’ HIV prevention push
- FDA Panel Backs Two Peptides For Compounding, Rejects One
- Aurenar lands $5.7M seed funding round for non-invasive neuromodulation platform
- Industry survey finds MA enrollees have lower out-of-pocket costs than those in traditional Medicare
- How Accurate Are Photo-Based Calorie Apps? 4 Are Put To The Test
- Procode AI secures $10M series A for AI-powered RCM for surgical billing
- Intermountain Health acquiring interests in 2 Idaho hospitals for $795M
- Sarepta taps AbbVie, Tessera vet Severino to write Duchenne firm's next chapter
- FDA approves Otsuka’s ADHD drug Simtriyo, teeing up its ‘next major CNS launch’
- On 4th try, Outlook scores FDA nod for reformulated version of Roche's Avastin for AMD
- AZ stays on track for $80B revenue goal as cancer meds, rare disease sales help offset Ultomiris miss
- Popular School Cafeteria Meals Need An Update To Meet Healthy Food Standards, Researchers Say
- Ovarian Syndrome Quadruples Heart Disease Risk In Women, Major Study Concludes
- Weed-Killing Chemical, Glyphosate, Linked To Premature Births In Humans, Study Says
- Legend Biotech CEO abruptly steps down without permanent replacement
- 'The Child Is Terrified': Doctors On Front Lines Of Measles Comeback Speak Out
- 'Yo-yo' Weight Loss Linked To Decline In Muscle Mass
- Tracking State Rural Health Transformation Plans
- Trump Administration Demands Hospitals Share Emergency Room Records
- As AI scribe adoption grows, researchers at Suki challenge the industry's quality playbook
- Journalists Assess Risks of Tick Bites, Wildfire Smoke, Rising Health Costs
- Salesforce lands $1.6B Veteran Affairs deal to integrate AI into healthcare workflows
- FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
- Frequent Marijuana Use Linked To Higher Stress Hormone Levels
- Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback
- Novo escalates Lilly false advertising suit with planned bid to halt comparative ads
- Amgen hands in data package in hopes of FDA hearing for Tavneos defense
- Another setback for Ipsen's Albireo portfolio as Bylvay flunks phase 3 trial
- Flourish Health secures $26M to scale intensive youth mental healthcare
- Back Pain? Try Swimming, Study Says
- Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
- Money Problems Might Make Your Brain Old Before Its Time, Study Suggests
- Merck stages expanded access to monthly HIV PrEP pill ahead of approval
- Black MS Patients Dying Younger Than White Ones, Study Finds
- Public Health Improvements Stall Amid Trump's DEI Crackdown
- To Afford Aging in Place, Older Adults Turn to ‘Golden Girls’ Housing
- Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey
- Many U.S. Schools Unprepared To Help Concussed Students Return To The Classroom
- Nearly 1.6 Million Dozen Eggs Pulled From Shelves Over Salmonella Concerns
- Organized Sports Help Enhance Motor Skills In Children With Autism
- People Living Longer, But Spending More Years With Illness And Disability
- Exercise Underwhelms As A Hip Arthritis Treatment, Review Concludes
- Tongue Pacemaker Might Improve Sleep Apnea Patients' Health
- Poll: Costs Are Top Health Care Issue For Midterm Voters, But Fraud Tops GOP List
- Measles Cases Set 35-Year US Record With Months To Go In 2026
- Taylor Farms Faces Cyclospora Outbreak, Recalls And Political Questions
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- GLP-1 Use Surges Among Young People With Obesity
- 1 In 4 Americans Stuck In Jobs For Health Insurance, Survey Finds
- How Does ADHD Affect Athletes' Concussion Risk?
- TV Does Indeed Rot Your Brain, Study Says
- HaloMD's Patrick Velliky explains why No Surprises Act IDR enforcement matters
- The CSO Model Is Endangered. Here’s How Contract Field Organizations Must Evolve to Survive.
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
Michigan healthcare freedom community forum
Robert F. Kennedy, Jr. was excoriated by Democratic Senators during nomination hearings before the Senate Finance & the Health, Education, Labor and Pensions Committees. Curiously, RFK, Jr. happens to still be a Democrat. One possible reason for his abuse at the hand of his fellow Democrats would be the Democratic Senators consider him an apostate for participating in President Trump's campaign and victory. The other possibility is the Democratic Senators are owned body and soul by Big Pharma and other anti MAHA (Make America Healthy Again) interests.
The Democratic propagandists in the main stream media are not covering this story because Champagne Socialist Bernie Sanders and Heap Big Faker Elizabeth "Pocahontas" Warren seem to be the most thoroughly compromised, but the story is getting some traction in alternative media:
RFK Jr. Exposes Big Pharma-Backed Senators During His Confirmation Hearing
By RVM News Staff - January 31, 2025Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services (HHS) sparked contentious debate in the Senate this week, bringing renewed attention to the influence of pharmaceutical and health industry donations on lawmakers.
During a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on Thursday, Kennedy defended his record against critics while senators questioning him found their own financial ties to the healthcare industry under scrutiny.
Senate HELP Committee Chair Bill Cassidy (R-LA) questioned Kennedy’s past statements on vaccines, including those related to measles and Hepatitis B.
While expressing concerns over Kennedy’s views, Cassidy acknowledged the nominee’s broad popular support.
“My responsibility is to learn, to try to understand if you can be trusted to support the best public health,” Cassidy said.
“A worthy movement called MAHA [Make America Healthy Again] to improve the health of Americans, or to undermine it, always asking for more evidence and never accepting the evidence that is there. That’s my dilemma, man. So you may be hearing from me over the weekend.”
Meanwhile, Kennedy and his supporters have pointed to the role of pharmaceutical industry donations in the confirmation process.
“Our kids are getting sicker and sicker. All of the people here who are defending this current system, and defending these pharmaceutical profits, are taking huge amounts of money from the pharmaceutical industry,” Kennedy said.
“This is not making our country healthier. It’s making our country sicker. We need to get rid of these conflicts.”
The role of industry donations in the confirmation process has drawn heightened attention, particularly regarding members of the Senate Finance Committee and the HELP Committee.
The watchdog group OpenSecrets has tracked contributions from pharmaceutical companies, health professionals, and related industries to committee members over the past five years.
Senate Finance Committee Ranking Member Ron Wyden (D-OR) has received significant contributions from the health sector between 2019 and 2024, including $749,316 from health professionals, $652,004 from insurers, $539,242 from health services and HMOs, and $502,063 from the pharmaceutical industry.
His top donors include Blue Cross/Blue Shield and Centene Corporation.
Cassidy, who expressed uncertainty over Kennedy’s confirmation, received $1,623,298 from health professionals and $996,737 from the pharmaceutical industry from 2019 to 2025, with Ochsner Health System as one of his top donors.
Even senators known for their criticism of the pharmaceutical industry have come under scrutiny.
Sen. Elizabeth Warren (D-MA) raised concerns that Kennedy’s lawsuits against pharmaceutical companies could financially damage vaccine manufacturers.
However, Warren has received $498,074 from health professionals, $126,056 from the pharmaceutical industry, and $109,065 from hospitals and nursing homes over the same period.
Sen. Bernie Sanders (I-VT), a longtime critic of corporate influence, has received $115,690 from the pharmaceutical industry and $159,233 from the food and beverage industry.
Sen. Bernie Sanders speaks at Erie High School in support of the Harris/Walz presidential campaign in Erie on Oct. 26, 2024.
During Kennedy’s testimony, Sanders was challenged on the $1,417,633 in contributions from pharmaceutical industry employees during his 2020 presidential campaign.“The problem of corruption is not just in the federal agencies. It’s in the Congress too,” Kennedy said.
“Almost all the members of this panel, including yourself, are accepting millions of dollars from the pharmaceutical industry and protecting their interests.”
Sanders defended his contributions, stating, “I ran for president like you. I got millions and millions of contributions. They did not come from the executives, not one nickel of PAC money from the pharmaceutical industry. They came from workers.”
Beyond campaign contributions, several senators overseeing Kennedy’s confirmation hold personal financial interests in industries that could be affected by his policies.
Wyden’s spouse owns stock valued between $50,000 and $100,000 in Restaurant Brands International Inc., which owns Burger King, Popeyes, and Firehouse Subs, as well as an investment worth between $1,001 and $15,000 in Pfizer.
Sen. Susan Collins (R-ME), a member of the HELP Committee, has financial ties to multiple industries regulated by HHS.
Her spouse owns stocks valued between $15,000 and $50,000 in companies such as EcoLab Inc., The Hershey Company, Johnson & Johnson, Merck & Co., and Thermo Fisher Scientific Inc.
Sen. Mark Warner (D-VA) has between $1 million and $5 million invested in Health Velocity Capital I, LP, a hedge fund focusing on healthcare technology, along with between $250,000 and $500,000 in Health Velocity II, LP, a venture capital fund.
While many senators on both sides of the aisle remain skeptical of Kennedy’s nomination, some have voiced strong support.
Sen. Marsha Blackburn (R-TN), one of the top recipients of pharmaceutical industry contributions in 2023-2024, has endorsed Kennedy’s nomination.
“It’s time to confirm RFK Jr. as HHS Secretary. He is ready to MAHA,” Blackburn said during the Senate Finance Committee hearing.
Kennedy’s confirmation remains uncertain as senators weigh his nomination against their own industry ties, with both his critics and supporters facing public scrutiny over their financial relationships with the healthcare sector.
In the 2019-20 Congressional funding cycle, Sanders received more money from people employed in the field classified by Open Secrets as "pharmaceuticals/health products" ($1.4 million) than any other member of Congress. He also received roughly $400,000 from people employed in "pharmaceutical manufacturing."
Elizabeth Warren raked in roughly $5 million from the health industry during her presidential bid in 2020.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















